Related Experiment Video
Updated: Mar 31, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Percutaneous aortic valve closure for patients with left ventricular assist device-associated aortic insufficiency
Mohamad Alkhouli1, Betsy Melito1, Frederick S Ling1
1Division of Cardiovascular Diseases, University of Rochester Medical Center, Rochester, New York.
Abstract:
The development of de novo aortic insufficiency (AI) is a significant complication of long-term LVAD support, which can lead to ineffective support, decreased device durability, end organ malperfusion, and increased mortality. Surgical aortic valve (AV) closure has been the standard treatment for symptomatic patients, but is associated with high mortality and recurrence of AI. Percutaneous AV closure using the Amplatzer cribriform device is a feasible and may be the preferable option to treat LVAD-associated severe AI in high-surgical risk patients. Certain technical issues with this procedure should be taken into consideration to achieve optimal results. © 2015 Wiley Periodicals, Inc.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Cardiac Catheterization III: Left Heart Catheterization

